SEC Form SC 13G filed by Molecular Data Inc.

$MKD
Business Services
Consumer Discretionary
Get the next $MKD alert in real time by email
SC 13G 1 d306827dsc13g.htm SCHEDULE 13G SCHEDULE 13G

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. ___)*

 

 

Molecular Data Inc.

(Name of Issuer)

 

 

Class A ordinary shares, par value US$0.00005 per share

(Title of Class of Securities)

60852L106**

(CUSIP Number)

12/06/2019

(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☒ Rule 13d–1(b)

☐ Rule 13d–1(c)

☐ Rule 13d–1(d)

 

*

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

**

CUSIP number 60852L106 has been assigned to the American Depositary Shares (“ADSs”) of the issuer, which are quoted on The Nasdaq Stock Market LLC under the symbol “MKD.” Each ADS represents three Class A ordinary shares of the issuer.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


Page 2 of 5

 

CUSIP No. 60852L106

 

  (1)    

  Names of reporting persons

 

  TB Alternative Assets Ltd

  (2)  

  Check the appropriate box if a member of a group (see instructions)

  (a)  ☐        (b)  ☐

 

  (3)  

  SEC use only

 

  (4)  

  Citizenship or place of organization

 

  Cayman Islands

Number of

shares

 beneficially 

owned by

each

reporting

person

with:

   (5)    

  Sole voting power

 

  25,580,619*

   (6)  

  Shared voting power

 

  0

   (7)  

  Sole dispositive power

 

  25,580,619*

   (8)  

  Shared dispositive power

 

  0

  (9)    

  Aggregate amount beneficially owned by each reporting person:

 

  25,580,619

(10)  

  Check if the aggregate amount in Row (9) excludes certain shares (see instructions)

 

(11)  

  Percent of class represented by amount in Row (9)

 

  6.18%**

(12)  

  Type of reporting person (see instructions)

 

  IA, Investment Adviser

 

*

Number of shares beneficially owned as of 31 Dec 2021. Includes 1,145,285 American Depositary Shares (“ADSs”). Each ADS represents 3 Class A Ordinary Shares.

**

Calculation is based on 414,182,151 outstanding ordinary shares for all classes as of 31 Dec 2021.


Page 3 of 5

 

SCHEDULE 13G

 

Item 1(a)

Name of issuer: Molecular Data Inc.

 

Item 1(b)

Address of issuer’s principal executive offices

11/F, Building 15, 2177 Shenkun Road

Minhang District, Shanghai 201106

People’s Republic of China

2(a) Name of person filing: TB Alternative Assets Ltd

This statement is filed by TB Alternative Assets Ltd, an investment adviser registered under Section 203 of the Investment Advisors Act of 1940, with respect to the portion of the Class A Ordinary Shares (as defined by 2(d) below) held by Trustbridge Partners V LP, a Cayman business company that is controlled by TB Alternative Assets Ltd. TB Alternative Assets Ltd acts as the investment adviser of Trustbridge Partners V LP.

2(b) Address or principal business office or, if none, residence: c/o Maples Corporate Services Limited, Ugland House, Grand Cayman, Cayman Islands, KY1-1104

2(c) Citizenship: Cayman Islands

2(d) Title of class of securities: Class A Ordinary Shares, $0.0005 par value per share*

2(e) CUSIP No.: CUSIP number 60852L106 has been assigned to the American Depositary Shares (“ADSs”) of the issuer, which are quoted on The Nasdaq Stock Market LLC under the symbol “MKD.” Each ADS represents three Class A ordinary shares of the issuer.

 

Item 3.

If this statement is filed pursuant to §§240.13d–1(b) or 240.13d–2(b) or (c), check whether the person filing is a:

 

(a) [  ]

Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);

 

(b) [  ]

Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);

 

(c) [  ]

Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);

 

(d) [  ]

Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a–8);

 

(e) [X]

An investment adviser in accordance with §240.13d–1(b)(1)(ii)(E);

 

(f) [  ]

An employee benefit plan or endowment fund in accordance with §240.13d–1(b)(1)(ii)(F);

 

(g) [  ]

A parent holding company or control person in accordance with §240.13d–1(b)(1)(ii)(G);

 

(h) [  ]

A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

 

(i) [  ]

A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a–3);

 

(j) [  ]

A non-U.S. institution in accordance with §240.13d–1(b)(1)(ii)(J);


Page 4 of 5

 

(k) [  ]

Group, in accordance with §240.13d–1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d–1(b)(1)(ii)(J), please specify the type of institution: ________________________________

 

Item 4.

Ownership

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

(a) Amount beneficially owned: 25,580,619

(b) Percent of class: 6.18%


Page 5 of 5

 

SCHEDULE 13G

(c) Number of shares as to which the person has:

(i) Sole power to vote or to direct the vote: 25,580,619

(ii) Shared power to vote or to direct the vote: 0

(iii) Sole power to dispose or to direct the disposition of: 25,580,619

(iv) Shared power to dispose or to direct the disposition of: 0

 

Item 5.

Ownership of 5 Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [ ].

Dissolution of a group requires a response to this item.

 

Item 6.

Ownership of More than 5 Percent on Behalf of Another Person.

Not Applicable

 

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

Not Applicable

 

Item 8.

Identification and Classification of Members of the Group.

Not Applicable

 

Item 9.

Notice of Dissolution of Group.

Not Applicable

 

Item 10.

Certifications

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect other than activities solely in connection with a nomination under §240.14a-11.

Signatures

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Date: 02/10/2022    

Signature:

 

/s/ Shujun Li

    Name:  

Shujun Li

    Title:   Director

 

Get the next $MKD alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$MKD

DatePrice TargetRatingAnalyst
More analyst ratings

$MKD
Press Releases

Fastest customizable press release news feed in the world

See more
  • Molecular Data Inc. Receives NASDAQ Notification

    SHANGHAI, June 24, 2022  /PRNewswire/ -- Molecular Data, Inc. ("Molecular Data" or the "Company") (NASDAQ:MKD), a technology-driven platform in China, announced that it had received a letter from The Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company that to date, it has not regained compliance with the Rule 5250(c)(1). Since the Company is already before a Hearings Panel for its failure to comply with the $1.00 minimum bid price requirement set forth in Listing Rule 5550(a)(2),pursuant to Listing Rule 5810(d)(2), rather than submit a compliance plan for Staff's review, the Company is to address the matter before the Hearings Panel. About Molecular Data, Inc. Molecular Data Inc. is a

    $MKD
    Business Services
    Consumer Discretionary
  • Molecular Data Inc. Receives NASDAQ Notification Regarding Minimum Bid Requirements

    SHANGHAI, May 27, 2022 /PRNewswire/ -- Molecular Data, Inc. ("Molecular Data" or the "Company") (NASDAQ:MKD), a technology-driven platform in China, announced today that on May 25, 2021, it had received a letter from The Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company that its minimum closing bid price per share for its ordinary shares had fallen below $1.00 for a period of 30 consecutive business days and that the Company did not meet the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2). On November 29, 2021, the Company was provided with an additional 180 calendar day compliance period, or until May 23, 2022, to demonstrate compliance. On May 24, 2022, th

    $MKD
    Business Services
    Consumer Discretionary
  • Molecular Data Inc. Announces ADS Ratio Change

    SHANGHAI, May 20, 2022 /PRNewswire/ -- Molecular Data Inc. (NASDAQ:MKD) (the "Company") announced today a ratio change on its American Depositary Shares ("ADS") from the current one (1) ADS representing three (3) Class A ordinary shares to the new ratio of one (1) ADS representing forty-five (45) Class A ordinary shares (the "Ratio Change"). The effective date of the Ratio Change is expected to be May 23, 2022. Each ADS holder of record at the close of business on the date when the change in ADS ratio is effective will be required to surrender and exchange every fifteen (15) existing ADSs then held for one (1) new ADS. JPMorgan Chase Bank, N.A., as the depositary bank for the Company's ADS p

    $MKD
    Business Services
    Consumer Discretionary

$MKD
SEC Filings

See more

$MKD
Leadership Updates

Live Leadership Updates

See more
  • WATERDROP ANNOUNCES APPOINTMENT OF NEW INDEPENDENT DIRECTOR

    BEIJING, May 2, 2022 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE:WDH), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced the appointment of Mr. Ning Zhu as a new independent director to its board of directors (the "Board") and the resignation of Mr. Peng Shen as a member of the audit committee of the Board, both effective May 2, 2022. Mr. Zhu will also serve as a member of the audit committee of the Board. After the change, the Board will consist of nine members, three of whom are independent directors, and the audit committee will consist solely of independent directors. Mr. Ning Zhu has b

    $MKD
    $WDH
    Business Services
    Consumer Discretionary
    Specialty Insurers
    Finance
  • Molecular Data Inc. Announces Changes of Chief Financial Officer

    SHANGHAI, China, Dec. 02, 2020 (GLOBE NEWSWIRE) -- Molecular Data Inc. (“Molecular Data” or the “Company”) (Nasdaq: MKD), a leading technology-driven platform in China’s chemical industry, today announced that the Company has appointed Mr. Steven Foo as the new chief financial officer, effective December 1, 2020. Mr. Zhaohong Li has tendered his resignation as chief financial officer, for personal reasons. “We greatly appreciate the contributions that Zhaohong has made during his tenure with the Company, leading our IPO, and building a public company finance team. We respect Zhaohong’s decision and wish him the very best in his future pursuits,” said Dr. Dongliang Chang, Founder and Chair

    $MKD
    Business Services
    Consumer Discretionary

$MKD
Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more